Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · Real-Time Price · USD

13.01

-2.99 (-18.72%)

At close: May 18, 2026, 4:00 PM EDT

13.52

+0.51 (3.96%)

Pre-market: May 19, 2026, 5:42 AM EDT

Generate Biomedicines Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	May '26 May 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Market Cap	1,657	-	-
Enterprise Value	1,206	0	0
Debt / Equity Ratio	0.10	0.28	0.17
Debt / EBITDA Ratio	-	-0.31	-0.42
Debt / FCF Ratio	-	-0.34	-0.63
Net Debt / Equity Ratio	-0.88	0.25	0.73
Net Debt / EBITDA Ratio	-	0.69	1.74
Net Debt / FCF Ratio	-	0.75	2.61
Asset Turnover	-	0.08	0.04
Quick Ratio	8.85	2.69	4.55
Current Ratio	9.17	2.85	4.70
Return on Equity (ROE)	-	-82.06%	-51.13%
Return on Assets (ROA)	-	-55.37%	-37.96%
Return on Invested Capital (ROIC)	-	-293.84%	-202.39%
Return on Capital Employed (ROCE)	-	-69.18%	-45.63%
Buyback Yield / Dilution	-	-2.77%	-
Total Shareholder Return	-	-2.77%	-

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q